Cooperative Agreement U01DA063078

Award Date 7/15/25
Completion Date 5/31/30
Dollars Obligated $2.4M
Federal Grant Program
93.279
Assistance Type
Cooperative Agreement
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $2,223,769 to the University of California, San Diego (UCSD) to conduct research on the intertwined mechanisms of HIV and opioid use on mitochondrial-mediated inflammasome activation and neurotoxicity. The research aims to elucidate how the convergence of HIV infection and opioid use leads to more severe neurological consequences, including...
The National Institute on Drug Abuse (NIDA) awarded a $786,979 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of California, San Diego (UCSD) to implement a two-prong hybrid trial focused on improving identification and treatment of substance use disorder (SUD) among sexual and gender minorities of color (SGMC) in Chicago. The first prong involves implementing routine screening for SUD using the NIDA Quick Screen. The second prong is a social network...
The National Institute on Drug Abuse (NIDA) awarded a $558,085 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of California, Irvine (UCI) to support an interdisciplinary research initiative titled "DMFV-SCORCH Project". This 5-year project aims to uncover multi-scale dysregulations resulting from HIV and opioid use disorder (OUD) through population-scale single-nuclei sequencing data analysis and functional validations using advanced genomic...
This $3,096,164 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a study to evaluate the efficacy and implementation of a peer-led Motivational Interviewing (MI) intervention called MI-CHANCE. The intervention aims to promote uptake of drug checking services (DCS) and safer drug use behaviors among people who use drugs (PWUD) in San Diego County to reduce overdose incidence. The 5-year study will...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $200,446 to the University of California, San Diego (UCSD) to conduct a mixed-methods study on the impact of novel housing programs on overdose outcomes among unhoused people who use drugs in San Diego, California. The key objectives of the study are to: 1) analyze longitudinal data on the effects of involuntary displacement and housing program...
The National Institute on Drug Abuse (NIDA) awarded a $687,416 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The grant supports research to develop therapeutically effective latency-promoting agents (LPAs) that can "block" HIV reactivation and "lock" HIV in a silenced state, even in the presence of addictive substances, for people living...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $3,086,472 to the University of Rhode Island on September 15, 2024. The objective of this 5-year project is to evaluate the spillover effects of HIV interventions among marginalized populations, particularly young Black men who have sex with men (BMSM), who use illicit substances. The project will leverage data from three existing network studies in Chicago,...
The National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $460,432 Project Grant to the Regents of the University of Minnesota to develop and pilot a comprehensive telehealth program at syringe service programs (SSPs) to engage people who inject drugs (PWID) into the HIV care continuum. The key products and services to be delivered include: Conducting formative research to understand determinants of HIV and addiction among...
The National Institute on Drug Abuse (NIDA) awarded a $3,067,394 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Kentucky Research Foundation. The grant, titled "Engaging People Who Use Drugs in Harm Reduction Service Delivery: An Intravention to Reduce Risk of HIV, HCV, Overdose, and Injection-Related Infections in Rural Appalachia," will test a peer-driven approach to address unmet harm reduction needs in two rural Kentucky...

This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $2,437,310 project at the University of California, San Diego (UCSD) to prospectively study the intersection between substance use, HIV, and related comorbidities in a binational cohort of people who inject drugs (PWID) in San Diego County. The 5-year project aims to track emerging substance use trends and evaluate the impact of harm reduction services, such as naloxone and drug testing vending machines, on HIV incidence among PWID. Key research objectives include examining predictors of HIV and hepatitis C incidence, analyzing comorbidities and molecular clustering of infections, and assessing the impact of structural interventions like homeless encampments and drug checking services on prevention outcomes.

Generated 8/5/25, 3:06 AM